ouabain has been researched along with Biliary Tract Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ablinger, C; Bekric, D; Beyreis, M; Dobias, H; Jakab, M; Kiesslich, T; Kittl, M; Mayr, C; Neureiter, D; Neureiter, E; Pichler, M; Prinz, F; Ritter, M | 1 |
1 other study(ies) available for ouabain and Biliary Tract Cancer
| Article | Year |
|---|---|
Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Biliary Tract Neoplasms; Humans; Ouabain; Sodium-Potassium-Exchanging ATPase | 2023 |